Stratification by Hb levels within the erythrocytosis group in this study revealed no significant association with thrombosis risk, consistent with Gangat et al.'s finding of no direct link between Hb levels and thrombosis in SGLT-2 inhibitor-associated erythrocytosis [11]. Here, SLC5A2 is linked to polycythemia.